This company is no longer active
Chr. Hansen Holding Toekomstige groei
Future criteriumcontroles 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Chr. Hansen Holding.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
Chemicals winstgroei | 22.4% |
Inkomstengroei | n/a |
Toekomstig rendement op eigen vermogen | 14.8% |
Dekking van analisten | Low |
Laatst bijgewerkt | 15 Dec 2023 |
Recente toekomstige groei-updates
Recent updates
Be Wary Of Chr. Hansen Holding (CPH:CHR) And Its Returns On Capital
Dec 31Is Chr. Hansen Holding (CPH:CHR) Using Too Much Debt?
Dec 13Chr. Hansen Holding (CPH:CHR) Will Be Hoping To Turn Its Returns On Capital Around
Jun 26These 4 Measures Indicate That Chr. Hansen Holding (CPH:CHR) Is Using Debt Reasonably Well
May 21Chr. Hansen Holding (CPH:CHR) Could Be Struggling To Allocate Capital
Mar 28Chr. Hansen Holding's (CPH:CHR) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 14Chr. Hansen Holding (CPH:CHR) Is Paying Out A Larger Dividend Than Last Year
Oct 29Chr. Hansen Holding (CPH:CHR) Is Increasing Its Dividend To €7.04
Oct 15Here's What's Concerning About Chr. Hansen Holding's (CPH:CHR) Returns On Capital
Sep 13These 4 Measures Indicate That Chr. Hansen Holding (CPH:CHR) Is Using Debt Reasonably Well
Aug 29A Look At The Intrinsic Value Of Chr. Hansen Holding A/S (CPH:CHR)
Aug 13Capital Allocation Trends At Chr. Hansen Holding (CPH:CHR) Aren't Ideal
Jun 12Chr. Hansen Holding (CPH:CHR) Seems To Use Debt Quite Sensibly
May 24A Look At The Fair Value Of Chr. Hansen Holding A/S (CPH:CHR)
May 09There Are Reasons To Feel Uneasy About Chr. Hansen Holding's (CPH:CHR) Returns On Capital
Mar 06Does Chr. Hansen Holding (CPH:CHR) Have A Healthy Balance Sheet?
Feb 19Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
8/31/2026 | 1,573 | 341 | 267 | 452 | 4 |
8/31/2023 | 1,334 | 227 | 180 | 317 | N/A |
5/31/2023 | 1,310 | 229 | 171 | 320 | N/A |
2/28/2023 | 1,294 | 229 | 133 | 276 | N/A |
11/30/2022 | 1,259 | 228 | 128 | 270 | N/A |
8/31/2022 | 1,218 | 225 | 167 | 309 | N/A |
5/31/2022 | 1,183 | 230 | 191 | 327 | N/A |
2/28/2022 | 1,146 | 221 | 228 | 354 | N/A |
11/30/2021 | 1,102 | 209 | 233 | 352 | N/A |
8/31/2021 | 1,077 | 199 | 155 | 311 | N/A |
5/31/2021 | 1,038 | 199 | 169 | 318 | N/A |
2/28/2021 | 1,014 | 213 | 208 | 358 | N/A |
11/30/2020 | 994 | 222 | 224 | 374 | N/A |
8/31/2020 | 970 | 232 | 246 | 365 | N/A |
5/31/2020 | 798 | 218 | 280 | 369 | N/A |
2/29/2020 | 844 | 221 | 223 | 326 | N/A |
11/30/2019 | 888 | 224 | 212 | 324 | N/A |
8/31/2019 | 937 | 229 | 180 | 299 | N/A |
5/31/2019 | 1,152 | 246 | 174 | 306 | N/A |
2/28/2019 | 1,132 | 240 | 190 | 313 | N/A |
11/30/2018 | 1,112 | 233 | 181 | 295 | N/A |
8/31/2018 | 1,097 | 228 | 195 | 302 | N/A |
5/31/2018 | 1,084 | 226 | 164 | 271 | N/A |
2/28/2018 | 1,080 | 224 | 168 | 270 | N/A |
11/30/2017 | 1,075 | 224 | 181 | 286 | N/A |
8/31/2017 | 1,063 | 224 | 178 | 284 | N/A |
5/31/2017 | 1,035 | 212 | N/A | 290 | N/A |
2/28/2017 | 1,007 | 205 | N/A | 260 | N/A |
11/30/2016 | 976 | 192 | N/A | 246 | N/A |
8/31/2016 | 949 | 184 | N/A | 245 | N/A |
5/31/2016 | 927 | 179 | N/A | 226 | N/A |
2/29/2016 | 905 | 174 | N/A | 237 | N/A |
11/30/2015 | 885 | 172 | N/A | 239 | N/A |
8/31/2015 | 859 | 163 | N/A | 222 | N/A |
5/31/2015 | 830 | 150 | N/A | 205 | N/A |
2/28/2015 | 800 | 141 | N/A | 188 | N/A |
11/30/2014 | 773 | 133 | N/A | 178 | N/A |
8/31/2014 | 756 | 132 | N/A | 176 | N/A |
5/31/2014 | 745 | 145 | N/A | 174 | N/A |
2/28/2014 | 738 | 142 | N/A | 182 | N/A |
11/30/2013 | 731 | 135 | N/A | 186 | N/A |
8/31/2013 | 738 | 138 | N/A | 190 | N/A |
5/31/2013 | 730 | 126 | N/A | 185 | N/A |
2/28/2013 | 719 | 125 | N/A | 175 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Insufficient data to determine if CHR's forecast earnings growth is above the savings rate (0.7%).
Winst versus markt: Insufficient data to determine if CHR's earnings are forecast to grow faster than the Danish market
Hoge groeiwinsten: Insufficient data to determine if CHR's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: Insufficient data to determine if CHR's revenue is forecast to grow faster than the Danish market.
Hoge groei-inkomsten: Insufficient data to determine if CHR's revenue is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: CHR's Return on Equity is forecast to be low in 3 years time (14.8%).